Clinical trials
Phase 3 Attention Deficit Disorder with Hyperactivity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 4 |
| Eli Lilly and Company | 3 |
| Rhodes Pharmaceuticals, L.P. | 3 |
| BioMarin Pharmaceutical | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Sanofi | 1 |
| The Canadian College of Naturopathic Medicine | 1 |
| University of Alberta | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 15 |
| Phenylketonurias | 1 |
| Sleep Initiation and Maintenance Disorders | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.